US 12364693
Methods of treating metabolic diseases with fused bicyclic pyrazoles
granted A61KA61K31/437A61K31/451
Quick answer
US patent 12364693 (Methods of treating metabolic diseases with fused bicyclic pyrazoles) held by Belite Bio, Inc expires Mon Jul 17 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Belite Bio, Inc
- Grant date
- Tue Jul 22 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 17 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K31/437, A61K31/451, A61K31/4523, A61K31/4535